Terug
Dagbereik
€ 20,68
€ 21,33
52-Weeksbereik
€ 19,50
€ 34,13
Volume
270.097
50D / 200D Gem.
€ 21,19
/
€ 25,08
Vorige Slotkoers
€ 20,97
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (631 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 34,3 | 0,2 |
| P/B | 1,8 | 3,0 |
| ROE % | 5,1 | 3,6 |
| Net Margin % | 6,0 | 3,8 |
| Rev Growth 5Y % | 4,3 | 9,9 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 25,00
+17.8%
Forward K/W
29,00
Forward WPA
€ 0,73
WPA Groei (sch.)
+0,0%
Omzet Sch.
326,28M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 0,00
€ 0,00 – € 0,00
|
361,17M | 1 |
| FY2027 |
€ 0,82
€ 0,81 – € 0,83
|
342,98M | 3 |
| FY2026 |
€ 0,73
€ 0,72 – € 0,74
|
326,28M | 3 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-23 | € 0,11 | € 0,18 | +63,6% |
| 2025-11-03 | € 0,17 | € 0,20 | +17,6% |
| 2025-08-04 | € 0,16 | € 0,18 | +12,5% |
| 2025-05-05 | € 0,16 | € 0,14 | -12,5% |
| 2025-02-24 | € 0,13 | € 0,16 | +23,1% |
| 2024-10-21 | € 0,13 | € 0,19 | +46,2% |
| 2024-07-22 | € 0,12 | € 0,14 | +16,7% |
| 2024-04-22 | € 0,11 | € 0,17 | +54,5% |
Dividend History
3 yr streakYield
0,01%
Payout Ratio
0,20%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 09, 2026 | Mar 20, 2026 | € 0,04 | 0,57% |
| Nov 17, 2025 | Nov 28, 2025 | € 0,03 | 0,51% |
| Aug 18, 2025 | Aug 29, 2025 | € 0,03 | 0,45% |
| May 19, 2025 | May 30, 2025 | € 0,03 | 0,41% |
| Mar 10, 2025 | Mar 21, 2025 | € 0,03 | 0,36% |
| Nov 04, 2024 | Nov 15, 2024 | € 0,03 | 0,38% |
| Aug 05, 2024 | Aug 16, 2024 | € 0,03 | 0,39% |
| May 03, 2024 | May 17, 2024 | € 0,03 | 0,48% |
| Mar 08, 2024 | Mar 22, 2024 | € 0,03 | 0,39% |
| Dec 08, 2023 | Dec 22, 2023 | € 0,03 | 0,38% |
| Sep 15, 2023 | Sep 29, 2023 | € 0,03 | 0,35% |
| Jun 09, 2023 | Jun 23, 2023 | € 0,03 | 0,21% |
| Apr 14, 2023 | Apr 28, 2023 | € 0,03 | 0,09% |
| Mar 05, 2018 | Apr 03, 2018 | € 1,00 | 4,14% |
Belangrijkste Punten
Revenue grew 4,32% annually over 5 years — modest growth
Debt/Equity of 0,04 — conservative balance sheet
Generating 59,63M in free cash flow
P/E of 34,34 — premium valuation
Cash machine — converts 325,12% of earnings into free cash flow
Capital efficient — spends only 1,21% of revenue on capex
Groei
Revenue Growth (5Y)
4,32%
Revenue (1Y)4,26%
Earnings (1Y)-8,32%
FCF Growth (3Y)-1,74%
Kwaliteit
Return on Equity
5,14%
ROIC4,12%
Net Margin6,03%
Op. Margin6,66%
Veiligheid
Debt / Equity
0,04
Current Ratio0,96
Interest Coverage0,00
Waardering
P/E Ratio
34,34
Forward P/E29,00
P/B Ratio1,78
EV/EBITDA30,06
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4,26% | Revenue Growth (3Y) | 4,38% |
| Earnings Growth (1Y) | -8,32% | Earnings Growth (3Y) | 9,80% |
| Revenue Growth (5Y) | 4,32% | Earnings Growth (5Y) | 33,10% |
| Profitability | |||
| Revenue (TTM) | 304,06M | Net Income (TTM) | 18,34M |
| ROE | 5,14% | ROA | 3,52% |
| Gross Margin | 64,74% | Operating Margin | 6,66% |
| Net Margin | 6,03% | Free Cash Flow (TTM) | 59,63M |
| ROIC | 4,12% | FCF Growth (3Y) | -1,74% |
| Safety | |||
| Debt / Equity | 0,04 | Current Ratio | 0,96 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,20% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 3 yrs | ||
| Valuation | |||
| P/E Ratio | 34,34 | Forward P/E | 29,00 |
| P/B Ratio | 1,78 | P/S Ratio | 2,07 |
| PEG Ratio | -4,98 | Forward PEG | N/A |
| EV/EBITDA | 30,06 | Fwd EV/EBITDA | 9,30 |
| Forward P/S | 1,93 | Fwd Earnings Yield | 3,45% |
| FCF Yield | 9,47% | ||
| Market Cap | 629,85M | Enterprise Value | 608,38M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 304,06M | 291,65M | 279,06M | 266,83M | 256,71M |
| Net Income | 18,34M | 20,01M | 15,21M | 12,09M | 5,85M |
| EPS (Diluted) | 0,61 | 0,66 | 0,50 | 0,39 | 0,18 |
| Gross Profit | 196,86M | 193,71M | 184,04M | 175,68M | 165,68M |
| Operating Income | 20,24M | 21,29M | 16,02M | 12,45M | 8,06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 520,37M | 510,77M | 499,94M | 497,74M | 486,75M |
| Total Liabilities | 166,35M | 151,41M | 159,19M | 163,68M | 147,73M |
| Shareholders' Equity | 354,02M | 359,36M | 340,75M | 334,06M | 339,02M |
| Total Debt | 14,68M | 20,17M | 20,25M | 23,32M | 29,11M |
| Cash & Equivalents | 36,16M | 59,47M | 40,33M | 46,02M | 46,91M |
| Current Assets | 119,66M | 153,12M | 130,21M | 114,38M | 106,85M |
| Current Liabilities | 124,15M | 115,69M | 118,36M | 117,21M | 100,35M |